Signaturefd LLC Buys 8,467 Shares of agilon health, inc. (NYSE:AGL)

Signaturefd LLC grew its position in shares of agilon health, inc. (NYSE:AGL) by 143.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 14,388 shares of the company’s stock after acquiring an additional 8,467 shares during the quarter. Signaturefd LLC’s holdings in agilon health were worth $27,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently made changes to their positions in AGL. Intech Investment Management LLC purchased a new position in agilon health during the third quarter worth about $228,000. Citigroup Inc. lifted its position in shares of agilon health by 2,251.5% during the 3rd quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock worth $7,971,000 after buying an additional 1,941,993 shares in the last quarter. Algert Global LLC boosted its stake in shares of agilon health by 80.2% in the 3rd quarter. Algert Global LLC now owns 184,530 shares of the company’s stock worth $725,000 after buying an additional 82,123 shares during the last quarter. Dynamic Technology Lab Private Ltd bought a new position in shares of agilon health in the third quarter valued at approximately $171,000. Finally, Quantbot Technologies LP bought a new position in shares of agilon health in the third quarter valued at approximately $1,742,000.

agilon health Trading Down 0.2 %

Shares of AGL opened at $4.47 on Wednesday. The business’s 50-day moving average price is $3.58 and its 200-day moving average price is $2.95. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. agilon health, inc. has a twelve month low of $1.50 and a twelve month high of $7.73. The stock has a market cap of $1.84 billion, a PE ratio of -4.76 and a beta of 0.67.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on the company. Stifel Nicolaus boosted their price objective on agilon health from $2.00 to $3.00 and gave the stock a “hold” rating in a research report on Wednesday, February 26th. Citigroup raised shares of agilon health from a “sell” rating to a “neutral” rating and boosted their price target for the stock from $1.75 to $2.25 in a report on Friday, January 10th. Needham & Company LLC restated a “hold” rating on shares of agilon health in a research report on Friday, March 21st. Royal Bank of Canada lifted their price objective on shares of agilon health from $3.00 to $3.50 and gave the stock an “outperform” rating in a research report on Wednesday, February 26th. Finally, Sanford C. Bernstein increased their target price on shares of agilon health from $2.50 to $3.15 and gave the company a “market perform” rating in a research report on Wednesday, January 15th. Two analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and two have given a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $3.95.

agilon health Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.